Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where D.N. Sharma is active.

Publication


Featured researches published by D.N. Sharma.


Indian Journal of Pediatrics | 1991

Bacterial meningitis in India: An IJP survey

S. K. Kabra; Praveen Kumar; I. C. Verma; Dilip Mukherjee; Bandana Hom Chowdhary; Supratik Sengupta; Ranjit Singh; S. P. Khatua; N. Miglani; Kuldeep Mohan Sehai; D.N. Sharma; K. V. Prakash; A. K. Dutta; Patwari Ak; Satinder Aneja; D. Chandra

ConclusionsIt can be concluded that bacterial meningitis is an important cause of childhood morbidity and mortality. Isolation of causative pathogenes is poor in our country. A routine gram staining of CSF and use of rapid diagnostic kits with better culture facilities would be helpful in improving the outcome. In first 3 months of life, therapy should include one of the 3rd generation cephalosporins with an aminoglycoside. For meningitis in age groups between 3 months to 12 years, chloramphenicol and ampicillin should be the first line empirical therapy. If gram-ve organisms are suspected or isolated, one of the 3rd generation cephalosporins with or without an aminoglycoside is good alternative. The treatment can be stopped in uncomplicated case after 7–10 days (5 days of afebride period) in meningitis caused by meningococcus, pneumococcus andH. infuenzae. For BM caused by gram-ve bacilli treatment for 21 days is recommended. There is no need to perform CSF examination at the conclusion of therapy in cases of bacterial meningitis beyond neonatal period. There is a need to further evaluate therapeutic regimens like chloramphenicol alone, ceftriaxone home therapy, especially for rural areas etc. to decrease the cost of hospitalisation in referral hospitals.


Contraception | 2000

Anti-nidatory effect of vaginally administered (Ala8,13,18)-magainin II amide in the rhesus monkey

Latika Dhawan; Debabrata Ghosh; P.G.L. Lalitkumar; D.N. Sharma; Bill L. Lasley; James W. Overstreet; Jayasree Sengupta

The hypothesis that timed application of a potent anti-microbial, anti-tumor agent like magainin peptides can inhibit blastocyst implantation was examined in the present study using the rhesus monkey as the primate model. Incidence of pregnancy, vaginal bleeding patterns, serum levels of progesterone, estrogen and monkey chorionic gonadotropin were examined following vaginal administration of (Ala8,13,18)-magainin II amide, a synthetic analogue of magainin 2, via tampon during days 20 to 26 of mated cycles. Implantation occurred in two out of three animals following administration of 0.25 mg magainin, while administration of 0.5 mg (Ala8,13,18)-magainin II amide resulted in inhibition of implantation in all females with no change in lengths of treatment cycles, and subsequent cycles. It appears from the present study that, besides being a local microbicidal agent, intravaginal administration of (Ala(8,13,18))-magainin II amide is a potential anti-implantation strategy for intercepting pregnancy.


Contraception | 2000

Anti-nidatory effect of vaginally administered fumagillin in the rhesus monkey

P.G.L. Lalitkumar; Jayasree Sengupta; Latika Dhawan; D.N. Sharma; Bill L. Lasley; James W. Overstreet; Debabrata Ghosh

In the present study, fumagillin, which is an antibiotic with potent angiostatic activity secreted from Aspergillus fumigatus was administered intravaginally during peri-implantation stage in the rhesus monkey and its effects on ovarian function, blastocyst implantation and pregnancy outcome in the rhesus monkey were investigated. Female monkeys (n = 18) showing normal menstrual cycles were vaginally inserted with tampons containing fumagillin (0 mg/animal in group 1; 1 mg/animal in group 2; 2 mg/animal in group 3; 4 mg/animal in group 4) on cycle day 20 of the mated treatment cycle, and these were removed on day 26 of the treatment cycle. Pregnancy was found to occur in animals treated with 1 mg and 2 mg fumagillin. However, animals treated with 4 mg fumagillin remained non-pregnant along with decreased (p <0.001) concentration of progesterone in circulation during the luteal period compared with that in normal, non-mated, ovulatory cycle.


Contraception | 1995

Effects of testosterone buciclate on testicular and epididymal sperm functions in bonnet monkeys (Macaca radiata)

S. Kinger; P.C. Pal; M. Rajalakshmi; P.K. Suresh^Kumar; D.N. Sharma; J.S. Bajaj

The effects of testosterone buciclate (TB), a long-acting androgen ester given i.m. at four sites (20 mg/site) on days 1 and 91 of the study period (360 days), on reproductive and hormonal parameters were evaluated in five adult male bonnet monkeys; untreated animals (n = 5) acted as controls to monitor seasonal changes in these parameters. In control animals, testicular volume remained unchanged throughout the study; sperm count, motility and gel penetrability decreased while the percentage of spermatozoa showing retention of cytoplasmic droplet and coiled tail increased in June-July (days 210-240), preceded by reduction in serum testosterone (T) levels on days 120-150 (March-April). The TB-treated animals showed reduced testicular volume (days 90-270), suppressed sperm motility and gel penetrability (days 45-240 except on day 120), decreased sperm count (days 75-270), and an increased percentage of spermatozoa showing retention of cytoplasmic droplet and coiled tail (days 45-240 except on day 120). Even though serum T levels remained elevated until day 300, these levels were within the physiological range. The changes induced by TB were reversible. The suppression of testicular and epididymal functions by TB indicates that this long-acting androgen may have the potentiality to induce and maintain reversible sterility, but further evaluation needs to be carried out to develop an appropriate dosage regimen that would prevent return to normal functions in order to develop this long-acting androgen as a hormonal male contraceptive.(ABSTRACT TRUNCATED AT 250 WORDS)


Journal of the Egyptian National Cancer Institute | 2016

Invasive lobular carcinoma of the male breast: A rare histology of an uncommon disease

Rituraj Upadhyay; Pavnesh Kumar; D.N. Sharma; K.P. Haresh; Subhash Gupta; Pramod Kumar Julka; G.K. Rath; Himani Bhankar

Male breast carcinoma is a rare malignancy comprising less than 1% of all breast cancers. It is a serious disease with most patients presenting in advanced stages. Infiltrating ductal carcinoma is the most common histology while lobular carcinoma represents less than 1% of all these tumors. We report a case of locally advanced lobular carcinoma of breast in a 60 year old male.


Asian Pacific Journal of Cancer Prevention | 2016

Quality of Life of Patients with Advanced Cervical Cancer before and after Chemoradiotherapy.

Neha Dahiya; Anita Shankar Acharya; Damodar Bachani; D.N. Sharma; Subhash Gupta; K.P. Haresh; Gayatri Rath


International Journal of Research in Commerce and Management | 2012

11 . NPA MANAGEMENT IN PUBLIC SECTOR BANKS: A STUDY OF CANARA BANK AND STATE BANK OF INDIA

R. Dhanuskodi; Ahmad Bawa Abdul-Qadir; Mansur Lubabah Kwanbo; Nguyen Phi Tan; Mehtab Arshad Butt; Dhanunjay Gonuguntla; M. Murugan; K. P. V. Ramana Kumar; D.N. Sharma; Mudita Gupta; K. Ramesh; A. Sudhakar; Pearly Jerry; Annie Kavita


International Journal of Radiation Oncology Biology Physics | 2018

Clinical Outcome of Brainstem Glioma Treated with or Without Concurrent Chemoradiotherapy: An Institutional Retrospective Analysis of 71 Patients

G.K. Rath; A.K. Gandhi; Supriya Mallick; D.N. Sharma


The Journal of Obstetrics and Gynecology of India | 2017

Socio-Demographic, Reproductive and Clinical Profile of Women Diagnosed with Advanced Cervical Cancer in a Tertiary Care Institute of Delhi

Neha Dahiya; Damodar Bachani; Anita Shankar Acharya; D.N. Sharma; Subhash Gupta; K.P. Haresh


International Journal of Radiation Oncology Biology Physics | 2017

Poster ViewingImpact of Brachytherapy use on Clinical Outcome of Elderly Patients of Carcinoma Cervix treated with Definitive Radiation Therapy

A.K. Gandhi; D.N. Sharma; Sunesh Kumar; G.K. Rath

Collaboration


Dive into the D.N. Sharma's collaboration.

Top Co-Authors

Avatar

G.K. Rath

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

K.P. Haresh

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Subhash Gupta

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Pramod Kumar Julka

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

A.K. Gandhi

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Anita Shankar Acharya

Lady Hardinge Medical College

View shared research outputs
Top Co-Authors

Avatar

Damodar Bachani

Lady Hardinge Medical College

View shared research outputs
Top Co-Authors

Avatar

Debabrata Ghosh

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jayasree Sengupta

All India Institute of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge